Turkey Next Generation Sequencing (NGS) Market to 2032
Overview
The Turkey Next Generation Sequencing (NGS) Market is expected to reach a 193.17 USD Billion by 2032 and is projected to grow at a CAGR of 17.93% from 2025 to 2032.
Revenue, 2024 (USD Billion)
74.04
Forecast, 2032 (USD Billion)
193.17
CAGR, 2024 - 2032
17.93%
Report Coverage
Turkey
Turkey Next Generation Sequencing (NGS) Market 2018-2032 USD Billion
Turkey Next Generation Sequencing (NGS) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 74.04 USD Billion
- Projected Market Size (2032): 193.17 USD Billion
- CAGR (2025-2032): 17.93%
Key Findings of Turkey Next Generation Sequencing (NGS) Market
- The Turkey Next Generation Sequencing (NGS) Market was valued at 193.17 USD Billion in 2024.
- The Turkey Next Generation Sequencing (NGS) Market is likely to grow at a CAGR of 17.93% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Precision Medicine in Application Segment accounted for the largest share of the market with a revenue of 74.04 USD Billion
- The fastest growing segment Pharmaceuticals Microbiology in Application Segment grew Fastest with a CAGR of 19.32% during the forecast period from 2024 to 2032.
Turkey Next Generation Sequencing (NGS) Market Scope
Turkey Next Generation Sequencing (NGS) Market Segmentation & Scope
End User
- Others
- Contract Research Organizations (CROS)
- Clinical Laboratories
- Hospitals & Clinics
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
Application
- Others
- Food Pathogen Screening
- Agricultural & Animal Research
- Diagnostics
- Pharmaceuticals Microbiology
- Precision Medicine
- Drug & Biomarker Discovery
Distribution Channel
- Others
- Retail Sales
- Direct Tender
Product & Service
- Instruments
- Services
- Consumables
Technology
- Others
- Sequencing By Ligation (SBL)
- Sequencing By Synthesis (SBS)
Turkey Next Generation Sequencing (NGS) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 74.04 USD Billion |
| Market Value in 2032 | 193.17 USD Billion |
| CAGR (2025-2032) | 17.93% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End User,Application,Distribution Channel,Product & Service,Technology |
Regional Insights:
-
Leading Market (2024-2032): Turkey, leading in terms of revenue 74.04 USD Billion in 2024
- Key Country: Turkey, leading in terms of revenue with value of 74.04 USD Billion in 2024.
Segments and Scope
-
Turkey Next Generation Sequencing (NGS) Market to 2032, By End User
- Pharmaceutical & Biotechnology Companies is the largest segment in Turkey Next Generation Sequencing (NGS) Market to 2032 with a revenue of 28.93 USD Billion in the year 2024.
- Pharmaceutical & Biotechnology Companies is the Fastest growing segment in Turkey Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 18.95 % in forecast period 2025-2032.
-
Turkey Next Generation Sequencing (NGS) Market to 2032, By Application
- Precision Medicine is the largest segment in Turkey Next Generation Sequencing (NGS) Market to 2032 with a revenue of 74.04 USD Billion in the year 2024.
- Pharmaceuticals Microbiology is the Fastest growing segment in Turkey Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 17.93 % in forecast period 2025-2032.
-
Turkey Next Generation Sequencing (NGS) Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Turkey Next Generation Sequencing (NGS) Market to 2032 with a revenue of 44.68 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in Turkey Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 18.19 % in forecast period 2025-2032.
-
Turkey Next Generation Sequencing (NGS) Market to 2032, By Product & Service
- Consumables is the largest segment in Turkey Next Generation Sequencing (NGS) Market to 2032 with a revenue of 37.09 USD Billion in the year 2024.
- Services is the Fastest growing segment in Turkey Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 17.72 % in forecast period 2025-2032.
-
Turkey Next Generation Sequencing (NGS) Market to 2032, By Technology
- Sequencing By Synthesis (SBS) is the largest segment in Turkey Next Generation Sequencing (NGS) Market to 2032 with a revenue of 44.95 USD Billion in the year 2024.
- Sequencing By Synthesis (SBS) is the Fastest growing segment in Turkey Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 18.14 % in forecast period 2025-2032.
Turkey Next Generation Sequencing (NGS) Market Company Share Analysis
| Company Name |
|
||
| Merck KGaA | |||
| Thermo Fisher Scientific Inc. | |||
| QIAGEN | |||
| Charles River Laboratories | |||
Turkey Next Generation Sequencing (NGS) Market Geographical Sales Distribution, 2018-2032 USD Billion
Turkey Next Generation Sequencing (NGS) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Turkey Next Generation Sequencing (NGS) Market is segmented based on Segmentation End User,Application,Distribution Channel,Product & Service,Technology.
Turkey Next Generation Sequencing (NGS) Market was valued at USD 74.04(Revenue in USD Billion) in 2020.
Turkey Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 17.93% during the forecast period of 2024 to 2032.
The Precision Medicine segment is expected to dominate the Turkey Next Generation Sequencing (NGS) Market, holding a largest market share of 74.04 USD Billion in 2024
Coming Soon....
Turkey Next Generation Sequencing (NGS) Market Scope
Turkey Next Generation Sequencing (NGS) Market Segmentation & Scope
End User
- Others
- Contract Research Organizations (CROS)
- Clinical Laboratories
- Hospitals & Clinics
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
Application
- Others
- Food Pathogen Screening
- Agricultural & Animal Research
- Diagnostics
- Pharmaceuticals Microbiology
- Precision Medicine
- Drug & Biomarker Discovery
Distribution Channel
- Others
- Retail Sales
- Direct Tender
Product & Service
- Instruments
- Services
- Consumables
Technology
- Others
- Sequencing By Ligation (SBL)
- Sequencing By Synthesis (SBS)
Frequently Asked Questions
The Turkey Next Generation Sequencing (NGS) Market is segmented based on Segmentation End User,Application,Distribution Channel,Product & Service,Technology.
Turkey Next Generation Sequencing (NGS) Market was valued at USD 74.04(Revenue in USD Billion) in 2020.
Turkey Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 17.93% during the forecast period of 2024 to 2032.
The estimated market value of the Turkey Next Generation Sequencing (NGS) Market for final year is USD 193.17 (USD Billion).
Turkey Next Generation Sequencing (NGS) Market Company Profiling
Frequently Asked Questions
The Turkey Next Generation Sequencing (NGS) Market is segmented based on Segmentation End User,Application,Distribution Channel,Product & Service,Technology.
Turkey Next Generation Sequencing (NGS) Market was valued at USD 74.04(Revenue in USD Billion) in 2020.
Turkey Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 17.93% during the forecast period of 2024 to 2032.
The estimated market value of the Turkey Next Generation Sequencing (NGS) Market for final year is USD 193.17 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.